Results 161 to 170 of about 1,804,540 (378)
Molecular Oncology, EarlyView.This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani +14 more
wiley +1 more source
Molecular Oncology, EarlyView.B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez +17 more
wiley +1 more source
Angiogeneza u centralnom nervnom sistemu - uloga faktora rasta vaskularnog endotela [PDF]
Vojnosanitetski Pregled, 2005 Lačković Vesna +4 more
doaj +1 more source
An Address ON MALINGERING, VALETUDINARIANISM, AND THEIR PREVENTION: Delivered Before the Pathological Society of Manchester [PDF]
, 1913 B. Bramwell
openalex +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Molecular Oncology, EarlyView.Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.
American Journal of Obstetrics and Gynecology, 2015 C. Kim +5 more
semanticscholar +1 more source